SPRB Spruce Biosciences, Inc.

Fundamentals / CIK 0001683553 / USD

Spruce Biosciences, Inc. reported $0 in revenue and a net loss of $67.15M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SPRB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$15.54M$7.77M$0-$50.45MFY 2019 Net Income: -$13.09M2019FY 2020 Net Income: -$29.54M2020FY 2021 Net Income: -$42.29M2021FY 2022 Revenue: $0FY 2022 Net Income: -$46.18M2022FY 2023 Revenue: $10.09MFY 2023 Net Income: -$47.92M2023FY 2024 Revenue: $4.91MFY 2024 Net Income: -$53.04M2024FY 2025 Revenue: $0FY 2025 Net Income: -$38.97M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $4.91M $10.09M $0 -- -- --
Research & Development $19.52M $46.42M $49.43M $35.20M $30.70M $23.85M $10.82M
Total Operating Expenses $36.51M $61.06M $62.08M $47.28M $42.07M $29.42M $13.11M
Operating Income -$36.51M -$56.15M -$51.99M -$47.28M -$42.07M -$29.42M -$13.11M
EBITDA -$36.49M -$56.10M -$51.92M -$47.21M -$42.00M -$29.38M -$13.10M
Interest Expense $90K $307K $483K $420K $345K $323K $65K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$38.97M -$53.04M -$47.92M -$46.18M -$42.29M -$29.54M -$13.09M
Basic EPS -$50.83 -$96.40 -$93.23 -$147.37 -$136.09 -$370.68 -$1,287.22
Diluted EPS -$50.83 -$96.40 -$93.23 -$147.37 -$136.09 -$370.68 -$1,287.22
Basic Shares Outstanding 766.6K 550.1K 512.2K 312.9K 310.7K 79.7K 10.2K
Diluted Shares Outstanding 766.6K 550.1K 512.2K 312.9K 310.7K 79.7K 10.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $0 $697K
Research & Development $18.13M $12.16M $7.58M $4.10M $5.01M -$430K $10.84M $21.46M
Total Operating Expenses $23.98M $16.51M $11.99M $11.10M $8.23M $2.69M $14.49M $24.77M
Operating Income -$23.98M -$16.51M -$11.99M -$11.10M -$8.23M -$2.69M -$14.49M -$24.07M
EBITDA -$23.24M -$15.88M -$11.73M -$11.10M -$8.23M -$2.69M -$14.49M -$24.07M
Interest Expense $1.20M $1.10M $674K $6.0K $19K $29K $36K $56K
Net Income -$24.01M -$16.23M -$12.27M -$14.65M -$8.21M -$2.07M -$14.04M -$23.56M
Basic EPS -$8.51 -$6.68 -$8.94 -- -$14.58 -$3.50 -$23.95 --
Diluted EPS -$8.51 -$6.68 -$8.94 -- -$14.58 -$3.50 -$23.95 --
Basic Shares Outstanding 2.8M 2.4M 1.4M -- 563.1K 591.1K 586.1K --
Diluted Shares Outstanding 2.8M 2.4M 1.4M -- 563.1K 591.1K 586.1K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $48.91M $38.75M $96.34M $24.49M $42.75M $157.2M $3.92M
Short-Term Investments -- -- $0 $54.59M $46.22M -- --
Cash & Short-Term Investments $48.90M $38.80M $96.30M $79.10M $88.97M $157.2M $3.92M
Accounts Receivable, Net -- -- -- $0 -- -- --
Other Current Assets $2.85M $2.28M $1.97M $1.21M $396K $276K $513K
Total Current Assets $52.11M $44.21M $102.2M $83.61M $91.89M $160.4M $4.65M
Property, Plant & Equipment, Net -- -- -- -- $140K $73K --
Long-Term Investments -- -- -- $0 $32.46M -- --
Other Non-Current Assets $243K $69K $582K $640K $653K $477K $40K
Total Non-Current Assets $909K $1.00M $1.76M $2.04M $34.59M $2.49M $40K
Total Assets $53.02M $45.21M $103.9M $85.65M $126.5M $162.9M $4.69M
Accounts Payable $943K $1.29M $3.33M $1.43M $2.82M $3.63M $1.88M
Short-Term Debt $0 $1.62M $1.62M $1.62M $0 $2.55M $1.25M
Deferred Revenue (Current) -- $0 $4.91M $0 -- -- --
Total Current Liabilities $10.09M $15.25M $24.46M $12.45M $8.87M $9.76M $4.30M
Long-Term Debt $0 $124K $1.72M $3.29M $4.88M $1.92M $3.19M
Deferred Revenue (Non-Current) -- -- -- $0 -- -- --
Other Non-Current Liabilities $0 $282K $236K $161K $73K $118K $20K
Total Non-Current Liabilities $419K $1.14M $2.97M $4.71M $6.24M $3.69M $3.21M
Total Liabilities $10.51M $16.39M $27.44M $17.16M $15.12M $13.46M $7.52M
Total Debt (incl. Leases) $736K $2.77M $4.61M $6.32M $6.53M $6.38M $4.45M
Common Stock $0 $0 $4.0K $3.0K $3.0K $2.0K $1.0K
Retained Earnings -$289.2M -$250.3M -$197.2M -$149.3M -$103.1M -$60.84M -$31.30M
Accumulated Other Comp. Income -- -- $0 -$558K -$184K -- --
Total Stockholders' Equity $42.52M $28.82M $76.51M $68.49M $111.4M $149.4M -$30.64M
Total Equity $42.52M $28.82M $76.51M $68.49M $111.4M $149.4M -$30.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $87.69M $96.30M $54.08M $48.91M $10.67M $16.39M $25.61M $38.75M
Cash & Short-Term Investments $87.70M $96.30M $54.10M $48.90M $10.70M $16.40M $25.60M $38.80M
Other Current Assets $203K $234K $88K $2.85M $2.92M $2.70M $2.06M $2.28M
Total Current Assets $90.30M $101.2M $55.03M $52.11M $14.52M $20.95M $30.58M $44.21M
Other Non-Current Assets $1.20M $1.18M $539K $243K $62K $64K $204K $69K
Total Non-Current Assets $1.65M $1.70M $1.13M $909K $797K $867K $1.07M $1.00M
Total Assets $91.95M $102.9M $56.17M $53.02M $15.31M $21.82M $31.65M $45.21M
Accounts Payable $2.73M $1.21M $2.68M $943K $1.39M $807K $1.88M $1.29M
Short-Term Debt $4.00M $2.50M $1.00M $0 $539K $943K $1.34M $1.62M
Deferred Revenue (Current) -- -- -- -- -- -- -- $0
Total Current Liabilities $18.71M $10.96M $11.78M $10.09M $9.43M $8.06M $15.67M $15.25M
Long-Term Debt $3.82M $4.59M $5.46M $0 $0 $0 $0 $124K
Other Non-Current Liabilities -- -- -- $0 $0 $0 $0 $282K
Total Non-Current Liabilities $6.94M $8.16M $9.73M $419K $500K $580K $659K $1.14M
Total Liabilities $25.65M $19.12M $21.52M $10.51M $9.93M $8.64M $16.32M $16.39M
Total Debt (incl. Leases) $7.98M $7.34M $6.80M $736K $1.04M $1.52M $2.00M $2.77M
Common Stock $0 $0 $0 $0 $0 $0 $4.0K $0
Retained Earnings -$341.7M -$317.7M -$301.5M -$289.2M -$274.6M -$266.4M -$264.3M -$250.3M
Total Stockholders' Equity $66.30M $83.73M $34.65M $42.52M $5.39M $13.18M $15.32M $28.82M
Total Equity $66.30M $83.73M $34.65M $42.52M $5.39M $13.18M $15.32M $28.82M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$38.97M -$53.04M -$47.92M -$46.18M -$42.29M -$29.54M -$13.09M
Depreciation & Amortization $21K $46K $70K $74K $68K $36K $12K
Stock-Based Compensation $2.57M $5.35M $4.62M $3.63M $3.96M $755K $196K
Change in Payables -$352K -$2.04M $1.91M -$1.40M -$805K -- --
Operating Cash Flow -$33.33M -$55.96M -$33.27M -$41.68M -$35.88M -$27.52M -$12.62M
Capital Expenditure -- $0 -$7.0K -$8.0K -$93K -$74K -$4.0K
Free Cash Flow -- -$55.96M -$33.28M -$41.69M -$35.97M -$27.59M -$12.62M
Purchases of Investments -- $0 -$11.88M -$36.80M -$79.08M -- --
Sales & Maturities of Investments -- $0 $67.67M $60.50M $0 -- --
Investing Cash Flow -- $0 $55.78M $23.69M -$79.17M -$74K -$4.0K
Financing Cash Flow $43.48M -$1.62M $49.14M -$241K $643K $181.0M $12.43M
Net Change in Cash $10.15M -$57.59M $71.64M -$18.23M -$114.4M $153.4M -$188K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.01M -$16.23M -$12.27M -$14.65M -$8.21M -$2.07M -$14.04M -$23.56M
Depreciation & Amortization $738K $631K $252K $5.0K $3.0K $7.0K $6.0K $9.0K
Stock-Based Compensation $1.10M $871K $689K $1.69M $415K -$77K $544K $961K
Change in Payables $1.52M -$1.43M $1.70M -$443K $579K -$1.07M $584K -$504K
Operating Cash Flow -$13.76M -$22.12M -$8.73M -$6.46M -$5.32M -$8.83M -$12.73M -$20.68M
Capital Expenditure $0 -$135K -$10K -- $0 $0 $0 --
Free Cash Flow -$13.76M -$22.25M -$8.74M -- -$5.32M -$8.83M -$12.73M --
Purchases of Investments -- -- -- -- -- -- -- $0
Sales & Maturities of Investments -- -- -- -- -- -- -- $0
Investing Cash Flow $0 -$135K -$10K -- $0 $0 $0 $0
Financing Cash Flow $5.16M $64.47M $13.92M $44.69M -$402K -$400K -$411K -$625K
Net Change in Cash -$8.60M $42.22M $5.17M $38.24M -$5.72M -$9.23M -$13.14M -$21.30M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -1143.4% -515.3% -- -- -- --
Net Profit Margin -- -1079.9% -475.0% -- -- -- --
Return on Equity (ROE) -91.7% -184.0% -62.6% -67.4% -38.0% -19.8% --
Return on Assets (ROA) -73.5% -117.3% -46.1% -53.9% -33.4% -18.1% -278.9%
Current Ratio 5.17x 2.90x 4.18x 6.72x 10.36x 16.43x 1.08x
Quick Ratio 4.85x 2.54x 3.94x 6.35x 10.03x 16.10x 0.91x
Debt to Equity 0.02x 0.10x 0.06x 0.09x 0.06x 0.04x --
Revenue Growth (YoY) -100.0% -51.3% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -7100.0% -3900.4% -1994.2% -1143.4%
Net Profit Margin -- -- -- -- -6869.3% -3721.2% -1906.2% -1079.9%
Return on Equity (ROE) -101.3% -61.3% -107.3% -91.7% -889.0% -366.8% -361.9% -184.0%
Return on Assets (ROA) -73.0% -49.9% -66.2% -73.5% -312.7% -221.5% -175.2% -117.3%
Current Ratio 4.83x 9.23x 4.67x 5.17x 1.54x 2.60x 1.95x 2.90x
Quick Ratio 4.69x 8.78x 4.59x 4.85x 1.14x 2.03x 1.63x 2.54x
Debt to Equity 0.12x 0.09x 0.20x 0.02x 0.19x 0.12x 0.13x 0.10x
Revenue Growth (YoY) -- -- -- -100.0% -100.0% -100.0% -100.0% -75.9%
Source: SEC EDGAR CompanyFacts (CIK 0001683553) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal